Methods: This was a retrospective study that included consecutive patients who underwent complex AWR using acellular dermal matrix (ADM) at a single center. We performed propensity score analysis for risk adjustment in multivariable analysis and for one-to-one matching.
Results: We included 511 patients who underwent AWR with ADM for repair of a complex hernia and/or oncologic resection from 2005 to 2015. One hundred thirty (25%) patients underwent XRT prior to AWR and 381 (75%) patients did not undergo XRT. With a mean follow-up of 30.0 months, a greater percentage of XRT AWR patients underwent flap reconstruction (14.6% vs 5.0%, p<0.001), whereas fewer underwent component separation (61.5% vs 71.4%, p=0.036) compared with non-XRT AWR patients. Both groups had similar rates of hernia recurrence (8.5% vs 9.4%) and surgical site occurrence (25.4% vs 23.4%).
When the treatment method was adjusted for the propensity score (in addition to the propensity score matched pairs), these results persisted. However, XRT AWR patients had a significantly shorter time to hernia recurrence compared to non-XRT AWR patients (among the 182 propensity score-matched pairs; 11.28 vs 21.73 months, p=0.028). Differences in hernia recurrence, surgical site occurrence, and wound healing complication rates were not observed.
Conclusions: Contrary to our hypothesis, the only difference detected between XRT AWR and non-XRT AWR patients was a shorter time to hernia recurrence seen in the XRT AWR group. Surgeons should be aware of the higher likelihood of needing a flap for skin replacement when performing AWR in the setting of XRT.